MBRS IMSD Program at Louisiana State University

路易斯安那州立大学 MBRS IMSD 项目

基本信息

项目摘要

DESCRIPTION (provided by applicant): An ambitious and innovative MBRS IMSD program at Louisiana State University would train twenty upper-level underrepresented minority undergraduate Scholars per year for careers as biomedical researchers. LSU has established a national reputation for increasing the numbers of underrepresented doctoral students entering academics and industry, particularly in the Department of Chemistry. The current goal is to extend this success to include the training of minority undergraduates in areas of interest to the NIH. A number of new initiatives and programs have recently been established at LSU, aimed at the education and retention of minority undergraduates particularly in the STEM (science, technology, engineering and mathematics) fields. The proposed IMSD program would service the needs of undergraduates with a specific interest in advanced biomedical research training. A select group of IMSD Student Scholars would be matched with faculty research preceptors according to their interest. They would work in the preceptors' laboratory for two academic years, receiving wages. Eight measurable goals would be used for program evaluation to meet NIH and institutional objectives: (i) 20 (10 junior and 10 LSU senior undergraduate) IMSD Scholars perform 15 hours per week of biomedical research for 9 (academic) months per year, as monitored by student time sheets and semester research progress reports, approved and signed by their respective preceptors, (ii) presentation of at least one lecture or poster of the student's research at a major regional or national scientific meeting and attendance at a second meeting, (iii) coauthorship of at least one peer-reviewed publication by at least 90% of the students, (iv) at least 95% attendance at IMSD meetings, seminars and relevant events, (v) selection and invitation by the IMSD students of three nationally renowned scientists per year who specialize in areas of interest to the students and the program, (vi) each of the IMSD Scholars maintaining at least a 3.0 GPA for full-time loads, (vii) the IMSD Scholars having at least a 90% graduation rate within four years of enrollment at LSU, (viii) the IMSD Scholars attaining at least a 90% success rate in graduate or professional school placement and/or biomedical research employment immediately upon graduation. The students would meet once a week during each semester in a seminar held by the PI/Project Director to address student needs and concerns and for educational enhancement activities. Activities would include presentations by LSU faculty and graduate students on biomedical research, the fine points of presentations of posters and lectures, info on standardized testing, selecting and applying to graduate school, laboratory safety, bioethics and biomedical issues of specific relevance to minority groups, financial aid and other relevant programs.
描述(由申请人提供):路易斯安那州立大学的雄心勃勃,创新的MBRS IMSD计划将培训每年二十个高层人数不足的少数族裔本科学者,因为其职业是生物医学研究人员。 LSU因增加代表性不足的博士生的数量而闻名于全国性,特别是在化学系中。目前的目标是扩展这一成功,以包括对NIH感兴趣领域的少数族裔大学生的培训。最近在LSU建立了许多新的计划和计划,旨在涉及少数族裔本科生的教育和保留,尤其是在STEM(科学,技术,工程和数学)领域。拟议的IMSD计划将满足对高级生物医学研究培训的特定兴趣的本科生需求。根据他们的兴趣,一组IMSD学生学者将与教师研究员相匹配。他们将在主教实验室工作两个学年,并获得工资。八个可衡量的目标将用于计划评估以实现NIH和机构目标:20(I)(10年级和10名LSU高级本科生)IMSD学者每周进行15小时的生物医学研究,每年9(学术)月份,每年受到学生的时间表和学期研究进度的报告,至少是一名portation Anders Anderations(至少是一名),至少是一名(至少是一名),至少是一名(II)(II)(II)。 regional or national scientific meeting and attendance at a second meeting, (iii) coauthorship of at least one peer-reviewed publication by at least 90% of the students, (iv) at least 95% attendance at IMSD meetings, seminars and relevant events, (v) selection and invitation by the IMSD students of three nationally renowned scientists per year who specialize in areas of interest to the students and the program, (vi) each of the IMSD学者至少保持3.0 GPA的全职负荷,(vii)IMSD学者在LSU入学后的四年内至少具有90%的毕业率,(viii)IMSD学者在研究生或专业学校的毕业后至少获得90%的成功率,并获得了至少90%的成功率。 PI/Project总监在每周的一次研讨会上每周开会一次,以满足学生的需求和疑虑以及教育增强活动。活动将包括LSU教职员工和研究生在生物医学研究,海报和讲座的详细介绍,有关标准化测试,选择和应用于研究生院,实验室安全,生物伦理学,生物伦理学以及与少数群体,经济援助和其他相关计划的特定相关性的信息。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Da Graca Vicente其他文献

Maria Da Graca Vicente的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
  • 批准号:
    82301753
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
肝细胞因子ORM2通过抑制Kupffer细胞激活改善非酒精性脂肪性肝炎的作用及机制研究
  • 批准号:
    82300966
  • 批准年份:
    2023
  • 资助金额:
    20 万元
  • 项目类别:
    青年科学基金项目
CD36/FABP4/CPT1轴介导脂肪酸转运促进白血病干细胞的维持在白血病化疗耐药中的作用及机制研究
  • 批准号:
    82300206
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
放射后早期神经元-星形胶质细胞脂肪酸代谢耦联对正常脑组织免疫微环境的重塑及其机制研究
  • 批准号:
    82373516
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
高原低氧上调肝脏ANGPTL4基因的表达导致巨噬细胞M1/M2比例失衡从而促进肝脂肪化的机制研究
  • 批准号:
    82360333
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Household Air Pollution, Adiposity, and Cardiorenal Disease Risk in Children
家庭空气污染、肥胖和儿童心肾疾病风险
  • 批准号:
    10739062
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Exosomes and insulin action in metabolically healthy and unhealthy obesity
外泌体和胰岛素在代谢健康和不健康肥胖中的作用
  • 批准号:
    10721302
  • 财政年份:
    2023
  • 资助金额:
    $ 2.4万
  • 项目类别:
Prenatal Exposure to Metal Mixtures: Childhood Adiposity and Adipokines
产前接触金属混合物:儿童肥胖和脂肪因子
  • 批准号:
    10387995
  • 财政年份:
    2022
  • 资助金额:
    $ 2.4万
  • 项目类别:
Preclinical Validation of PPARg Acetylation Inhibitors for Diabetes Prevention and Treatment
PPARg 乙酰化抑制剂预防和治疗糖尿病的临床前验证
  • 批准号:
    10430186
  • 财政年份:
    2021
  • 资助金额:
    $ 2.4万
  • 项目类别:
Therapeutic Development of Osteogenic Oxysterol, Oxy133, for Spine Fusion
用于脊柱融合的成骨氧甾醇 (Oxy133) 的治疗开发
  • 批准号:
    10478295
  • 财政年份:
    2021
  • 资助金额:
    $ 2.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了